1. 프로그램 명칭

영문명: Human Hematopoietic Stem Cells and Gene Transfer: Lessons from CGD Human Trials

국문명: 혈액줄기세포와 유전자 전달: CGD(만성육아종 질환) 임상시험 사례연구를 통한 세포/유전자치료의 전망

2. 일정: 2009년 2월 19일 (목)

3. 장소: 서울대학교 임상의학연구소 강의실

4. 주최: 한국유전자치료학회(KSGT), 대한소아임상면역학회, 대한소아혈액종양학회 공동주최

5. 주관 및 후원: 바이로메드

6. 프로그램

[ Session I ]

02:00 – 02:10         Opening Address

Dr. Je-Ho Lee
President of the Korean Society of Gene Therapy and
Professor, Samsung Medical Center

02:10 – 02:30         Overview on Gene Modification of Hematopoietic Stem Cells Using CGD as Model Case

Dr. Sunyoung Kim

Professor, Seoul National University and CEO, ViroMed Co., Ltd.

02:30 – 03:00         Gene Therapy for CGD: The Frankfurter Experience and Beyond

Dr. Manuel Grez

Georg-Speyer-Haus

03:00 – 03:30         Gene Therapy for CGD: Current Studies and Future Approaches

Dr. Harry L Malech

Head, Genetic Immunotherapy Section,

National Institute of Allergy and Infectious Diseases, National Institutes of Health

03:30 – 03:50         Break

03:50 – 04:20         UK Experiences of Gene Therapy for CGD

Dr. Adrian J Thrasher

Director, Centre for Immunodeficiency, Institute of Child Health

04:20 – 04:50         Gene Therapy for CGD: Korean Experiences

Dr. Joong Gon Kim
Professor, Seoul National University College of Medicine

04:50 – 05:20         Open Discussion

Moderator: Dr. Sunyoung Kim

Professor, Seoul National University and CEO, ViroMed Co., Ltd.

 [ Session 2 ]

05:30 –                 Closed Meeting (Garden View)